Analytics

Welcome to the Cell & Gene Therapy Analytics Hub

A path toward universal agreement on fulfilling the need for rapid and reliable sterility assays in gene therapy

A path toward universal agreement on fulfilling the need for rapid and reliable sterility assays in gene therapy

Harnessing AI and omics for next-generation gene therapy manufacturing

Harnessing AI and omics for next-generation gene therapy manufacturing

Richard Braatz, Irene Rombel

Navigating analytical and regulatory hurdles in early-phase clinical cell therapy development

Navigating analytical and regulatory hurdles in early-phase clinical cell therapy development

Advancing quality standards for gene therapies: a USP perspective

Advancing quality standards for gene therapies: a USP perspective

A novel PCR-free hybridization method for titering gene therapy vectors in crude cell lysates and various in-process matrices

A novel PCR-free hybridization method for titering gene therapy vectors in crude cell lysates and various in-process matrices

CAR-T manufacturing intensification: the next wave of CAR-T commercialization

CAR-T manufacturing intensification: the next wave of CAR-T commercialization

A Bersenev, E Kleiren, J Knighton et al

Innovator Insight

Developing autologous iPSC-based therapies for Parkinson’s disease treatment

Developing autologous iPSC-based therapies for Parkinson’s disease treatment

28 February 2025

Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors

Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors

J Hengst, Q Rafiq, R Ladi et al

27 February 2025

Innovator Insight

Achieving robust and scalable AAV empty/full capsid separation for gene therapy

Achieving robust and scalable AAV empty/full capsid separation for gene therapy

Julio Huato, Mark Schofield

26 February 2025

Innovator Insight

1
2
3
4
5
6
7
8
9
10
...
>
>>

Find the EV needle in the haystack with Leprechaun

Find the EV needle in the haystack with Leprechaun

Turbocharging pDNA production: a case study on optimization through novel technologies

Turbocharging pDNA production: a case study on optimization through novel technologies

Xiangming Gu, Lucas Smith

Spot-on, standard-free AAV titer and characterization with Stunner

Spot-on, standard-free AAV titer and characterization with Stunner

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Jens Björkman, Andreas Hecker

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

A Frazer, L R. Salvitti, S Lovatt et al

Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

Olaf Stamm, Horst Ruppach

Armor CAR T cells with enhanced potency for cancer immunotherapy

Armor CAR T cells with enhanced potency for cancer immunotherapy

Conducting rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

Conducting rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

M Dingle, A Carwell, M J. Miller et al

Fit-for-purpose analytical development for an emerging cell therapy landscape

Fit-for-purpose analytical development for an emerging cell therapy landscape

Jie Wei, Damian Marshall, Florian Durst

1
2
3
4
5
6
7
8
9
10
...
>
>>